Evidence mapPaperPMID 42098536Full record

SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Photobiomodulation for the treatment and prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: a systematic review and meta-analysis of randomized clinical trials published in the last six years.

Rojas G, Escalante-Parra R, Duarte A, Terán-Ángel G, Moreno-Garces P, Silveira Fm, Sanchez-Ramirez C

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rojas GDepartment of Oral and Maxillofacial Surgery, Hospital Militar "Doctor Carlos Arvelo", Caracas, Venezuela.ORCID http://orcid.org/0009-0002-1155-2671
Escalante-Parra RDepartment of Oral and Maxillofacial Surgery, Hospital Militar "Doctor Carlos Arvelo", Caracas, Venezuela.ORCID http://orcid.org/0000-0002-9000-8174
Duarte ADepartment of Oral and Maxillofacial Surgery, Hospital Militar "Doctor Carlos Arvelo", Caracas, Venezuela.
Terán-Ángel GUniversity of the Andes, Merida, Venezuela.ORCID http://orcid.org/0000-0002-2684-2308
Moreno-Garces PDepartment of Radiology, Faculty of Dentistry, Universidad Central de Venezuela, Caracas, Venezuela.ORCID http://orcid.org/0009-0001-1089-9721
Silveira FmDepartment of Diagnosis in Pathology and Oral Medicine, School of Dentistry, Universidad de Montevideo, Montevideo, Uruguay.ORCID http://orcid.org/0000-0001-9834-5194
Sanchez-Ramirez CDepartment of Oral and Maxillofacial Surgery, Hospital Militar "Doctor Carlos Arvelo", Caracas, Venezuela. odcarlossanchez@gmail.com.ORCID http://orcid.org/0000-0002-6098-5839

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo systematically evaluate and update the evidence about photobiomodulation therapy (PBMT) as a therapy for the prevention and/or treatment of oral mucositis (OM) induced by antineoplastic therapies.

methodsThis systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic literature search was conducted across PubMed, Web of Science, Scopus, and Embase as the primary databases. Additional searches were performed in the Virtual Health Library (VHL) and LILACS through the BIREME platform, as well as in Redalyc and the Wiley Online Library, covering the period from 2020 to 2026. Only randomized clinical trials published within the last six years investigating PBMT as a preventive or therapeutic intervention for oral mucositis (OM) in cancer patients receiving chemotherapy and/or radiotherapy were included.

resultsSeven studies comprising 329 patients were included. PBMT proved to be highly effective in the management of OM (RR 0.50, 95% CI 0.35-0.73). Moderate heterogeneity was observed across studies (I

conclusionEvidence from recent randomized clinical trials confirms that PBMT is highly effective for the management of oral mucositis, reducing its incidence and severity, improving quality of life and treatment adherence, and potentially lowering healthcare costs during cancer therapy.

Indexed as

Antineoplastic AgentsLow-Level Light TherapyNeoplasmsRadiation InjuriesStomatitisHumansRadiotherapyRandomized Controlled Trials as TopicAntineoplastic AgentsCancerChemotherapyOral MucositisPhotobiomodulationRadiotherapy

Identifiers

PMID42098536

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.